Baricitinib partially reversed pro-apoptotic changes, suppressing HIF-1a and cleaved Caspase-3, but further reduced Survivin and HTRA2, indicating selective modulation of apoptosis during infection (Fig. 4E and Supplementary Fig. S8C). Here, HTRA2 is linked to infection.